All about COVID-19

Coronavirus | A problematic testing strategy

Thermal screening of visitors at Allahabad High Court on March 16, 2020.   | Photo Credit: -

Even as the World Health Organization has been urging countries that have reported many laboratory-confirmed COVID-19 cases to become more aggressive in testing, India continues to have among the lowest testing rates in the world. In India, only those people with a travel history to high-risk COVID-19 affected countries or with close contacts to laboratory confirmed COVID-19 cases and with symptoms of the disease are being tested.

Also read: Coronavirus | Experts say India still in second transmission stage

Criteria for testing

If this does not instil confidence, Kerala, seen as a role model in India in containing highly pathogenic outbreaks, has further narrowed down the criteria for testing. On March 12, the Kerala Health Ministry issued revised testing guidelines based on current risk assessment. According to the guidelines, people with mild symptoms (low grade fever, mild sore throat, cough, rhinitis or diarrhoea) who have come from countries with ongoing COVID-19 local transmission and contacts of confirmed/suspect cases will not be tested for the virus.

“Testing is not going to change either the clinical course or management of the patient with mild symptoms,” the guidelines say. The rationale that testing people with mild symptoms that are non-specific would delay the testing of more deserving cases is problematic and may prove counterproductive.

According to Dr. Nivedita Gupta of the Indian Council of Medical Research, the maximum number of samples that the National Institute of Virology (NIV) unit in Alappuzha received in a single day was around 100. It is as low as 10 on some days. In a day or two, two more labs in the State will begin confirming cases without sending samples to the NIV unit in Alappuzha. One more lab is set to start screening samples early this week. Given that Kerala now has the capacity to test more samples each day, it is unclear why it has issued these revised guidelines. If this is an attempt to keep the numbers artificially low, it will prove counterproductive.

Also read: Explained | When can people transmit the novel coronavirus?

If the number of samples of people with mild symptoms to be tested each day is indeed delaying testing those with more severe symptoms at this early stage of the pandemic, it is worrying to imagine what the situation would look like if and when community spread becomes widespread in Kerala.

Since about 80% of those with COVID-19 exhibit only mild symptoms and recover without special treatment, not testing them would mean that a vast majority of cases will go undetected. This is wrong from the epidemiological point of view as the true case load will not be recorded. In fact, with the rest of the country looking up to Kerala in containing the spread of the virus, the State was expected to adopt a more expansive testing strategy — i.e., testing all contacts soon after being traced immaterial of clinical manifestation.

Fear of spread

As people with mild symptoms will not be tested now, the real danger of allowing them to spread the virus cannot be dismissed. A few studies as well as the experience of many countries show that infected people start spreading the virus even before symptoms show up. The infectiousness only increases when people start exhibiting symptoms. Though the guidelines say that contacts and people with travel histories should be under “strict home isolation”, the false sense of security when not tested might increase the likelihood of such people not following home isolation strictly. In fact, stricter quarantining would be needed for symptomatic people.

Also read: Coronavirus | India shares two SARS-CoV-2 genome sequences

When the State displays great rigour in tracing contacts and insists on home isolation for 14 days, not testing them when they show symptoms goes against the grain of the contact tracing strategy. There will be great danger of contact tracing backfiring when people who willingly self-isolate are not tested when symptoms show up. This is unethical too. Kerala cannot claim that there are no new cases and the pandemic is under control in the State when it does not test people in quarantine exhibiting mild symptoms.

This article is closed for comments.
Please Email the Editor

Printable version | Apr 17, 2021 12:49:22 AM |

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
You are reading
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story